Novo Nordisk is the leading
global healthcare Danish organization, founded in 1923. Main purpose of NOVO
NORDISK is to drive change to defeat diabetes and other serious chronic
diseases such as obesity, rare blood and endocrine disorders. From labs to factory
floors, Novo Nordisk is discovering and developing innovative biological
medicines and making them accessible to patients throughout the world. Diabetes
places a great burden on health systems and Novo Nordisk is committed to work
with health authorities and other partners to prevent and treat the disease.
Novo Nordisk is the leading
producer of the world's insulin and 36.3 million people are sing Novo Nordisk
diabetes care products across the Globe including Pakistan. Today, one in every
ten people in the World has diabetes, a figure that is projected to rise to one
in nine by 2045, if action is not taken. The cost and access to medical care
can place a devastating burden on individuals, their families, and even whole
societies. Long-term ambition of Novo Nordisk is to provide access to
affordable diabetes care for vulnerable patients in every country, especially
children living with type 1 diabetes, who face certain death in some parts of
the world without care and medicine. Novo Nordisk aims at preventing more than
100 million people from getting type 2 diabetes by 2045.
Novo Nordisk partners with
patients, policymakers, healthcare professionals and non-governmental
organizations to build awareness, advance prevention and expand access to care.
According to International Diabetes Federation, 33 million people are living
with diabetes in Pakistan, making it the 3rd largest population in terms of
number of diabetics after India and China. Novo Nordisk is committed to cure
diabetes in Pakistan and in partnership with Ministry of National Health
Services Regulations and Coordination through various initiatives, striving to
improve the awareness on diabetes. treatment and care of people with Diabetes
in Pakistan, ultimately preventing the debilitating complications of this
disease. In 2022, Novo Nordisk reached to around 2.6 million people through
diabetes awareness initiatives, trained 600 healthcare professionals including
doctors, nurses and pharmacists on management of diabetes. Novo Nordisk also
collaborated with Embassy of Denmark and Health Services Academy Islamabad to
commemorate World Diabetes Day 2022 at President House Islamabad to bring
Diabetes on National Agenda.
The Year 2023 marks a century of
innovation in medicine for Novo Nordisk, a company founded by Nobel Laureate
August Krogh and his wife Marie. One hundred years ago, a diagnosis of type 1
diabetes was a death sentence. In 1923, the founders
set out to change this reality.
This determination has driven them ever since, relentlessly turning challenges
into positive change for millions of people worldwide. As Novo Nordisk turns
100, it's time to renew the commitment to drive change for a healthy world
today, and for generations to come.
The 100-year anniversary of Novo
Nordisk is a landmark achievement in global healthcare to focus on unmet
societal and individual challenges, innovation, and its value to people
suffering with diabetes - including achievements over the past 100 years and a
commitment to continue innovation for years to come.
Issuance of commemorative postage
stamp on occasion of 100 years of Novo Nordisk is recognizing a century of
innovation and service. This would highlight the burgeoning rise of Non-
Communicable Diseases across the country. Saving lives must go together with improving
health and wellbeing with the ultimate aspiration: a world free from the burden
of disease. That is why there is a need to build awareness around these disease
areas which can ultimately reduce the burden of disease and help people live
healthier lives.
On 100 years of founding of Novo Nordisk, Pakistan Post is issuing a Commemorative Postage Stamp, titled "100 Years of NOVO NORDISK A CENTURY OF INNOVATION IN MEDICINE", of Rs.20/- denomination on 22nd September.2023.















